90 related articles for article (PubMed ID: 20359431)
1. Oral and dental findings in a child with growth hormone insensitivity syndrome.
Abanto J; Celiberti P; Alves FB; Rossier V; Vieira SA; Ciamponi AL; Raggio DP
J Dent Child (Chic); 2010; 77(1):54-8. PubMed ID: 20359431
[TBL] [Abstract][Full Text] [Related]
2. Consequences of not treating children with laron syndrome (primary growth hormone insensitivity).
Laron Z
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1243-8; discussion 1261-2. PubMed ID: 11964019
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z
Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
[TBL] [Abstract][Full Text] [Related]
5. Laron syndrome abnormalities: spinal stenosis, os odontoideum, degenerative changes of the atlanto-odontoid joint, and small oropharynx.
Kornreich L; Horev G; Schwarz M; Karmazyn B; Laron Z
AJNR Am J Neuroradiol; 2002 Apr; 23(4):625-31. PubMed ID: 11950656
[TBL] [Abstract][Full Text] [Related]
6. A novel growth hormone receptor gene deletion mutation in a patient with primary growth hormone insensitivity syndrome (Laron syndrome).
Yamamoto H; Kouhara H; Iida K; Chihara K; Kasayama S
Growth Horm IGF Res; 2008 Apr; 18(2):136-42. PubMed ID: 17728167
[TBL] [Abstract][Full Text] [Related]
7. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation.
Bernasconi A; Marino R; Ribas A; Rossi J; Ciaccio M; Oleastro M; Ornani A; Paz R; Rivarola MA; Zelazko M; Belgorosky A
Pediatrics; 2006 Nov; 118(5):e1584-92. PubMed ID: 17030597
[TBL] [Abstract][Full Text] [Related]
8. Long-term IGF-I treatment of children with Laron syndrome increases adiposity.
Laron Z; Ginsberg S; Lilos P; Arbiv M; Vaisman N
Growth Horm IGF Res; 2006 Feb; 16(1):61-4. PubMed ID: 16442822
[TBL] [Abstract][Full Text] [Related]
9. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.
Savage MO; Attie KM; David A; Metherell LA; Clark AJ; Camacho-Hübner C
Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):395-407. PubMed ID: 16932322
[TBL] [Abstract][Full Text] [Related]
10. [Delayed growth with raised circulating growth hormone and incapacity to produce somatomedin (dwarfism of Laron type)].
Rappaport R; Czernichow P; Prevost C; Jullien M
Ann Pediatr (Paris); 1977 Jan; 24(1):63-7. PubMed ID: 16211946
[No Abstract] [Full Text] [Related]
11. A 42-Year-Old Woman with Untreated Growth Hormone Insensitivity, Diabetic Retinopathy, and Gene Sequencing Identifies a Variant of Laron Syndrome.
Castilla-Cortazar I; De Ita JR; García-Magariño M; Aguirre GA; Castorena-Torres F; Valdez-Garcia JE; Ortiz-Urbina J; de la Garza RG; Fraustro-Avila E; Rodríguez-Zambrano MA; Elizondo MI
Am J Case Rep; 2019 May; 20():689-696. PubMed ID: 31086127
[TBL] [Abstract][Full Text] [Related]
12. Dubowitz syndrome: report of a case with emphasis on the oral features.
Chan KM; King NM
J Dent Child (Chic); 2005; 72(3):100-3. PubMed ID: 16568913
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic advances in growth hormone insensitivity.
David A; Metherell LA; Clark AJ; Camacho-Hübner C; Savage MO
Endocrinol Metab Clin North Am; 2005 Sep; 34(3):581-95, viii. PubMed ID: 16085161
[TBL] [Abstract][Full Text] [Related]
14. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome).
Laron Z
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():231-49. PubMed ID: 10698588
[TBL] [Abstract][Full Text] [Related]
15. Kabuki Syndrome with additional dental findings: a case report.
Cogulu D; Oncag O; Celen E; Ozkinay F
J Dent Child (Chic); 2008; 75(2):185-7. PubMed ID: 18647516
[TBL] [Abstract][Full Text] [Related]
16. A new autosomal recessive disorder resembling Weaver syndrome.
Teebi AS; Sundareshan TS; Hammouri MY; al-Awadi SA; al-Saleh QA
Am J Med Genet; 1989 Aug; 33(4):479-82. PubMed ID: 2596508
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone insensitivity syndrome: unusual oral manifestations.
Borges AH; Siqueira CR; Pedro FL; Palma VC; Sakai VT; Volpato LE
J Dent Child (Chic); 2013; 80(3):150-3. PubMed ID: 24351697
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatment.
Carel JC; Chaussain JL; Chatelain P; Savage MO
Diabetes Metab; 1996 Jul; 22(4):251-6. PubMed ID: 8767171
[TBL] [Abstract][Full Text] [Related]
19. [New molecular mechanisms of growth hormone insensitivity].
Edouard T; Raynal P; Yart A; Conte-Auriol F; Salles JP; Tauber M
Arch Pediatr; 2008 Feb; 15(2):179-88. PubMed ID: 18207712
[TBL] [Abstract][Full Text] [Related]
20. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
Wilton P
Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
